SANTA FE SPRINGS, Calif. (October 1, 2008) DNP International has announced the ownership of a manufacturing facility that will further fuel its strong presence in the raw material industry. The facility, located in the Jiangsu province of eastern China, allows DNP to advance its goals of guaranteeing consistent quality, competitive pricing and a stable supply of raw materials.

“It is important for our customers to know we are controlling the manufacturing process from the start to the final delivery,” said David Ji, president of DNP International. “The results we anticipate is improved quality, lower prices and more availability on a consistent level.

The Jiangsu facility has been in operation since last year prior to DNP taking ownership. DNP’s initial focus is to produce a line of Creatine products, which is currently in high demand. With the facility’s current capacity, DNP will be able to produce more than 4,000 metric tons of its Creatine line of products including 3,000 metric tons of its Monohydrate variation. Some of the products that customers may submit their blanket orders for include Creatine Anhydrous, Creatine Citrate, Creatine Gluconate, Creatine Phosphate, Creatine Ethyl Ester, Creatine Malate, Creatine Orotate and Creatine Alpha Keto Glutarate. Some of the products are already available for purchase and others will be available later this month. Customers may also request a sample prior to purchasing any of the products through their local sales representative.